Bonafide Targets of Deregulated microRNAs in Non-Small Cell Lung Cancer as Tool to Identify Novel Therapeutic Targets: A Review

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|1|55-72

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.1, 2017-02, pp. : 55-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-canonical IKKs, IKKε and TBK1, as novel therapeutic targets in the treatment of non-small cell lung cancer

By Kim Jae-Young   Beg Amer A   Haura Eric B  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 10, 2013-10 ,pp. : 1109-1112

Informa Healthcare

Access to resources Recommend Favorite

Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer: Update

By  

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 3, 2004-01 ,pp. : 253-256

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs in Non-small Cell Lung Cancer: Current Status and Future Therapeutic Promises

By  

Current Pharmaceutical Design, Vol. 20, Iss. 24, 2014-05 ,pp. : 3982-3990

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation Mechanism of MicroRNAs in Non-Small Cell Lung Cancer

By  

Current Pharmaceutical Design, Vol. 23, Iss. 39, 2018-02 ,pp. : 5973-5982

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 5, 2014-05 ,pp. : 475-485

Bentham Science Publishers

Access to resources Recommend Favorite